Basic standards for management of patients with common mental illnesses in primary care

Psychiatria Danubina

Volumn 17, Issue 3-4, 2005, Pages 205-220

  Agius, Mark ^a,e   Biočina, Sanja Martić ^b   Alptekin, Koksal ^c   Rotstein, Vladimir ^d   Morselli, Paolo ^e   Persaud, Albert ^e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Psychiatric Hospital Vrap e   (Croatia)

^c University of Ismir   (Turkey)

^d Public Initiatives on Psychiatry   (Russian Federation)

^e Department of Health Wellington House London ^*  (United Kingdom)

Author keywords

Anxiety disorders; Depression; Pharmacotherapy; Primary care; Psychological interventions; Psychosis

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; ARTICLE; CLINICAL PROTOCOL; COGNITIVE THERAPY; CONTINUING EDUCATION; CORRELATION ANALYSIS; DEPRESSION; DRUG DEPENDENCE; EUROPE; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HUMAN; MEDICAL EDUCATION; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOTHERAPY; STAFF TRAINING; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

ANXIETY DISORDERS; DEPRESSIVE DISORDER; ENGLAND; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; HUMANS; PATIENT CARE TEAM; PRIMARY HEALTH CARE; PSYCHOTIC DISORDERS; QUALITY ASSURANCE, HEALTH CARE; REFERRAL AND CONSULTATION;

EID: 28844453596     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (124)

1. Agius M: The Bedfordshire collection of Guidelines for Mental Health Problems in Primary Care. in PRIMHE Resource Pack, 2003.
2. Agius M Martic Biocina S Alptekin K Rotstein V Morselli P Persaud A.: Basic Standards for Management of Patients with Serious Mental Illness in the Community.Psychiatria Danubina 2005; 17:p42.
3. Agius M and Butler J: Enhancing the management of Primary CareMental Health. in PRIMHE Resource Pack, 2003.
4. Agius M Butler J The Development of an interface between Primary and Secondary Care In Mental Health, M.Agius J Butler Malta Medical Journal, 2003; 15;2,35.
5. Agius M Butler J: The CPN Liason Service J of primary care mental health (PRIMUE), 1999; 3:11-12.
6. Agius M John Butler: The Management of Mental Health in Primary and Secondary Care in L Cotterill &W Barr (EDS) Targeting in Mental Health- a Multidisciplinary Challenge Ashgate chapter, 2000; 13 245-255.
7. Agius M Butler J: The Management of Mental Health in Primary Care; The development of a training and facilitators' initiative South Bedfordshire Community Health Trust Journal of Clinical Practice, 1998; Vol 1 No. 2 pg 37-38.
8. Agius M, Butler J: Early Intervention and Primary Care 'Psychiartric care across cultures' First pan-Mediterranean conference on psychiatry and cultures p104 Malta November 2003.
9. Albright, A. Postpartum Depression: An Overview. Journal of Counselling & Development 71.
10. American Psychiatric Association: Practice guidelines for the treatment of patients with Panic Disorder. Am J Psychiatry. 1998; 155(supp) 1-26.
11. Anderson IM Tomenson BM: The efficacy of selective serotonin reuptake inhibitors in depression; a meta-analysis of studies against tricyclic antidepressants J Psychopharmacol, 1994; 8: 238-249.
12. Appleby L, Warner, R., Whitton, A. & Faragher, B: A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. British Medical Journal., 1997; 314:932.
13. Baldwin D et al: 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour. Int Clin Psychopharmacol, 1991; 6(suppl3) 49-55.
14. Barr W and Cotterill L: Mental Health Registers in Primary Care; a case study in service targeting. in L Cotterill &W Barr (EDS) Targeting in Mental Health- a Multidisciplinary Challenge Ashgate, 2000; chapter10 175-200.
15. Bazire S: Psychotropic Drug Directory 2000.
16. Beasley CH et al: Fluoxetine and suicide; a meta-analysis of controlled trials of treatment for depression. BMJ 1991; 303:685-692.
17. Bech P et al: Meta-analysis of randomised controlled trials of fluoxetine v placebo and tricyclic antidepressants in the short term treatment of major depression. British Journal of Psychiatry., 2000; 176:421-428.
18. Bingefors K et al: Antidepressant dose patterns in Swedish clinical practice Int ClinPsychopharmacol, 1997, 12:283-290.
19. Bhatti Ali, R. & Hussain, A. the Development & Evaluation of a Punjabi Postnatal Screening Questionnaire (PPNSQ) Bradford Community Health Trust. (Publication pending).
20. Bhugra, D: Influences of culture on presentation and management of patients. Principles of Social Psychiatry. (Blackwell, London), 1993.
21. Bollini P et al: Effectiveness of anti-depressants. Meta-analysis of dose-effect relationships in randomised clinical trials. British Journal of Psychiatry., 1999; 174: 297-303.
22. Burns T and Kendrick T: The primary care of patients with Schizophrenia; A search for good practice. British Journal of General Practice, 1997; 47:515-20.
23. Butler J: Mental health in primary care: an audit of training needs amongst primary care nurses. Bedfordshire & Luton Trust Journal. of Clinical Practice, 2000; 2(2):46-50.
24. Catalan J et al: Evaluation of a brief psychological treatment for emotional disorders in primary care. Psychol Med, 1991; 21:1013-1018.
25. Catalan J et al: The effects of not prescribing anxiolytics in General Practice. B J Psychiatry, 1984; 144:593-602.
26. Cipriani A et al: Suicide, depression and antidepressants.BMJ, 2005; 330:373-4.
27. Cox JL et al: Detection of postnatal depression; development of the 10 item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 1987; 150: 782-786.
28. Croudace T et al: Impact of the ICD-10 primary health care (PHC) diagnostic and management guidelines for mental disorders on detection and outcome in primary care. Cluster randomised controlled trial. British Journal of Psychiatry, 2003; 182:20-30.
29. De Rubeis RJ, Crits-Cristoph P: Empirically supported individual and group psychological treatments for adult mental disorders. J Consul Clin Psycol, 1998; 66(1):37-52.
30. Datto CJ et al: The pilot study of a telephone disease management program for depression. Gen Hosp Psychiatry., 2003; 25(3):169-177.
31. Donoghue J: Antidepressant use in primary care.. In Depression:Social and Economic Timebomb. Edited by Ann Dawson and Andre Tylee BMJ Books, 2001; p151-156.
32. Donoghue JM, Tylee A: The treatment of depression: prescribing patterns of anti-depressants in primary care in the UK. British Journal. of Psychiatry, 1996, 168:164-8.
33. Donoghue J Tylee A Wildgust HJ: Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom. Br J Psychiatry, 1996; 168:164-168.
34. Donoghue J: Suboptimal use of tricyclic antidepressants in primary care. Acta Psychiatrica Scandinavica, 1998; 98:429-431.
35. Drinkwater S: Improving mental health Liason in Primary Care. University of Luton, 2003.
36. Druss BC et al: Integrated medical care for patients with serious psychiatric illness; a randomised trial. Arch Gen Psychiatry., 2001; 58(9):861-868.
37. Dunn RL et al: Longitudinal patterns of antidepressant prescribing in primary care in the United Kingdom; comparison with treatment guidelines. J Psychopharmacol, 1999; 13:136-143.
38. Fergusson D et al: Association between suicide attempts and serotonin reuptake inhibitors; systematic review of randomised controlled trials. BMJ, 2005; 330:396-400.
39. Freeling P, Rao B, Paykel E et al: Unrecognised Depression in General Practice BMJ, 1985; 290:1880-1883.
40. Fridli K et al: Randomised controlled assessment of non-directive psychotherapy versus routine general practitioner care. Lancet, 1997; 350:1662-1665.
41. Gask L et al: Evaluating Models of working at the interface between Mental Health Services and Primary Care. British Journal of Psychiatry, 1997; 170:6-11.
42. Gloaguen V et al: A meta-analysis of the effects of cognitive therapy in depressed patients J Affect Disorders, 1998; 49:59-72.
43. Goldberg D and Jackson G: Interface between Primary Care and Specialist Mental Health Care. British Journal of General Practice, 1992; 42:267-69.
44. Goldberg D and Gournay K: The General Practitioner, The Psychiatrist, and the Burden of Mental Health Care. Maudsley Discussion Paper no 1. London, 1997.
45. Goldberg D and Huxley P: 'Filters in the pathway of care' in D Goldberd and P.Huxley (eds) Common Mental Disorders; a Biosocial Model. Tavistock/Routledge London, 1992.
46. Goldberg D Gask L Jenkins R Lewis B Paton J Sharp D Tylee A: WHO Guide to Mental Health in Primary Care. RSM, 2000.
47. Goldberg A Bridges K: Screening for psychiatric illness in general practice: the general practitioner versus the screening questionnaire. J. of Royal College of General Practitioners, 1987; 37:15-18.
48. Gould RA et al: Cognitive Behavioural and pharmacological treatment of generalised anxiety disorder; a preliminary meta-analysis. Behaviour Ther, 1997; 28(2):285-305.
49. GregorKJ et al: Outpatient antidepressant utilization in a Dutch sick fund. Am J Manag Care, 1998; 4:1150-1160.
50. Gunnell D et al: Selective serotonin uptake inhibitors. [SSRIs] and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ, 2005, 330:385-389.
51. Gunnell D et al: Antidepressants and suicide; what is the balance of benefit and harm? BMJ, 2004; 329:34-38.
52. Harvey L et al: A randomised controlled trial of counselling in primary care. Br J Gen Practice, 1998; 48:1043-1048.
53. Healy D Whitaker C: Antidepressants and suicide; risk benefit conundrums. J Psychiatry Neurosci, 2003; 28:331-7.
54. Healy D: Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors Psychother Psychosomat, 2003; 72:71-79.
55. Isometsa E et al: Inadequate dosaging in general practice of tricyclics vs. other antidepressants for depression Acta Psychiatrica Scandinavica, 1998; 98:451-454.
56. Jakovljević M: The rational use of anti-depressants; treating the whole patient. Medicus, 2004; 13:41-48.
57. Jick SS et al: Antidepressants and suicide. BMJ, 1995; 310:215-218.
58. Jick H et al: Antidepressants and the risk of suicidal behaviour. JAMA, 2004; 292:338-343.
59. Johnson DAW: Treatment of depression in General Practice BMJ, 1973; 1:18-20.
60. Johnson DAW: Depression; Treatment Compliance in General Practice. Acta Psychiatrica Scandinavica, 1981; 63(suppl 290):447-453.
61. Kahn A et al: Suicide rates in clinical trials of SSRIs, other antidepressants and placebo; analysis of FDA reports. Am J Psychiatry, 2003; 160:790-792.
62. Kendrick T et al: Provision of care to general practice patients with disabling long-term mental illness; a survey with 16 practices. British Journal of General Practice, 1994; 44:301-305.
63. Kendrick T et al: Role of general practitioners in care of long term mentally ill patients BMJ, 1991; 302:508-10.
64. Kerwick S, Jones R, Mann A: Mental Healthcare training priorities in general practice. British Journal of General Practice, 1997, 47:225-227.
65. Kozaric-Kovacic D and Jendricko T: Suicidality and depression. Medicus, 2004; 13:77-87.
66. Kumar, R: Postnatal mental illness: A transcultural perspective. Social Psychiatry, Psychiatric Epidemiology, 1994; 29:250-264.
67. Lader M Russel J: Guidelines for the prevention and treatment of benzodiazepine dependence; Summary of a report from the Mental Health Foundation. Addiction, 1993; 88(12):1707-1708.
68. Lader M Bond A: Interaction of pharmacological and psychological treatments of anxiety. B J Psychiatry, 1998; 173(supp34):165-168.
69. Lave J et al: Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry, 1998; 55(7):645-651.
70. Lobo A Campos R: Managing the Psychiatry/Primary care interface. In Depression and Physical illness edd Robinson M and Katona C Wiley, 1997; p38-66.
71. Lester H: A cluster randomised controlled trial of patient held medical records for people with schizophrenia receiving shared care., 2003; 53(488):197-203.
72. MacDonald TV et al: Antidepressant drug use in primary care; a record linkage study in Tayside Scotland. BMJ, 1996; 313:860-861.
73. Makaric G et al: Practical Guidelines for depression Treatment. Medicus, 2004; 13: 49-57.
74. Mann AH, Beizard R, Murray J, Smith JA, Botega N, MacDonald E, Wilkinson G: An evaluation of practice nurses working with general practitioners to treat people with depression. British J. of General Practice, 1998; 48:875-9.
75. Marks I Swinson RP: Alprasolam and exposure for panic disorder with agoraphobia; summary of London/Toronto Results. J Psychiatric Res, 1990; 24:100-101.
76. Martinez C. et al: Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression; nested case-control study. BMJ, 2005; 330:389-393.
77. Masand P et al: Suicidal ideation related to fluoxetine treatment. N Eng J Med, 1991; 324:420.
78. Medwar C: The antidepressant web-marketing depression and making medicines work, International journal of risk and safty in medicine, 1997; 10:75-126.
79. Murray B et al: Paroxetine treatment of generalised social phobia, (social anxiety disorder) a randomised controlled trial., 1998; 280:8.
80. Mynors-Wallace LM et al: Randomised Controlled Trial comparing problem solving treatment with amitryptyline and placebo for major depression in primary care. BMJ, 1995; 310:441-445.
81. Mynors-Wallace L et al: A randomized controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care. British Journal of Psychiatry, 1997; 170:113-119.
82. Nahas, V L.,Hillege, S. & Amasheh, N: Postpartum Depression: The lived experiences of Middle Eastern migrant women in Australia. Journal of Nurse Midwifery, 1999; 44, 65-74.
83. NHS Centre for reviews and Dissemination University of York: The treatment of depression in primary care. Effective Health Care March 1993(5) 1-12.
84. NICE Guidelines for the treatment of Depression 2005.
85. NICE Guidelines for the treatment of anxiety 2005.
86. Nutt D: Death and dependence; current controversies over the selective serotonin reuptake inhibitors. J Psychopharmacol., 2003; 17:355-64.
87. Onyett S, Pidd F, Cohen A, Peck E: Mental health service provision and the primary care team. Mental Health Review, 1996; 1:8-16.
88. Paykel ES and Priest RG: Recognition and Management of Depression in General Practice; Consensus Statement. BMJ, 1992; 305:1198-1202.
89. Paykel E. et al: Prediction of therapeutic benefit from amitriptyline in mild depression; a general practice, placebo controlled trial. Affective Disorders, 1988; 14:83-95.
90. Pereira Gray D: Depression and General Practice. In In Depression:Social and Economic Timebomb. Edited by Ann Dawson and Andre Tylee BMJ Books, 2001; p 77-84.
91. Sonuga-Barke,E J S.,Mistry, M. & Qureshi, S: The mental health of Muslim mothers in extended families living in Britain: The impact of intergenerational disagreement on anxiety and depression.British Journal of Clinical Psychology, 1998; 37:399-408.
92. Persaud, A.,Vellerman, R. & Templeton, L: Postnatal depression in women from the Black and Ethnic Minority communities in a Rural area.The Journal of Primary Care Mental Health, 2000; 3, 13-15.
93. Power P: The Development of the Lambeth Early Onset (LEO) and Oasis Service in South London. Advancing Practice in Bedfordshire, 2004; 1:2(Supplement 2004) p10.
94. Prien R Kupfer D: Continuation of drug therapy for major depressive episodes. How long should it be maintained? Am J Psychiatry, 1986, 143:18-23.
95. Reimherr F et al: Optimal length of continuation therapy for depression; a prospective assessment during long term fluoxetine treatment. Am J Psych, 1998; 155:1247-1253.
96. Roth AD and Fonagy P: What works for whom? A critical review of psychotherapy research. New York Guildford Press, 1996
97. Rothschild AJ Lokke CA: Reesposure to fluoxetine after serious suicide attempts by three patients. J Clin Psychiatry., 1991; 52:491-493.
98. RosholmJ-U et al: Outpatient utilization of antidepressants; a prescription database analysis. J Affect. Disord., 1993; 27:21-28.
99. Rouillon F et al: Etude pharmaco-epidemiologique de la consommation des antidepresseurs en population generale L'encephale; 1996; Sp 1;39-48.
100. Ruchin V Martin A: SSRIs and the developing brain. Lancet, 2005; 365:451-453.
101. Rutz W et al: An educational project on depression and its consequences; is frequency of major depression among Swedish men underrated resulting in high suicidality? Primary Care Psychiatry, 1995; 1:59-63.
102. Rutz W: Improving the recognition and monitoring of depressive conditions; implications for suicide prevention.. In Depression:Social and Economic Timebomb. Edited by Ann Dawson and Andre Tylee BMJ Books, 2001; p67-73.
103. Rutz W et al: Effects on an educational program for general practitioners in Gotland on the pattern of prescription of psychotropic drugs.Acta Psychiatrica Scandinavica, 1990; 82:399-403.
104. Rutz W et al: Long term effects of an educational program for general practitionersgiven by the Swedish Committee for the Prevention and treatment of depression. Acta Psychiatrica Scandinavica, 1992; 85:83-88.
105. Schulberg H et al: Best clinical practice; guidelines for managing major depression in primary care. J Clin Psych, 1999; 60(supp7):19-24.
106. Schulberg HC et al: Treating major depression in primary care practice. Eight month Clinical Outcomes. Arch Gen Psych., 1996; 53:913-919.
107. Scott A et al: Edinburgh Primary Care Depression Study.BMJ, 1991; 304:883-887.
108. Sheldon T et al: Examining the effectiveness of treatments for depression in general practice. J Mental Health., 1993; 2:141-156.
109. Sibbald B et al: Councellors in English and Welsh general practices,their nature and distribution BMJ, 1993; 306:29-33.
110. Singleton A Tylee A: Continuing medical education in mental illness; a Paradox for general practitioners. British Journal of General Practice., 1996, 46:339-341.
111. Song F et al: Selective serotonin reuptake inhibitors; mera-analysis of efficacy and acceptability. BMJ, 1993; 306:683-687.
112. Taylor D et al: Maudsley Guidelines, 2001.
113. Teicher MH et al: Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry., 1990; 147:207-210.
114. Thompson C et al: Effects of a clinical-practice guideline and practice based education on detection and outcome of depression in primary care; Hampshire Depression Project randomised control trial Lancet, 2000; 355:185-191.
115. Turton P, Tylee A, Kerry S: Mental Health training needs in general practice. Primary care psychiatry, 1995; 1:197-199.
116. Tylee A: RCGP Mental Health Management Course Journal of Primary Care Mental Health (PRIMHE), 1999; 1:13-4.
117. Tylee A: Management of Depression in Primary Care. In Depression:Social and Economic Timebomb. Edited by Ann Dawson and Andre Tylee BMJ Books, 2001; p85-92.
118. Upton MW et al: Evaluation of ICD-10 PHC mental health guidelines in detecting and managing depression within primary care. British Journal of Psychiatry, 1990; 175:476-487.
119. Ustun TB, Sartorius N: Mental Illness in General Health John Wiley, 1995.
120. Whittington CJ et al: Selective serotonin reuptake inhibitors in childhood depression; systematic review of published versus unpublished data. Lancet, 2004; 363:1341-1345.
121. Wilkinson G: The role of the practice nurse in the management of depression. Int Rev Psychiatry., 1992; 4:311-316.
122. Williams R: Establishing Mental Health Registers in General Practice in L Cotterill &W Barr (EDS) Targeting in Mental Health- a Multidisciplinary Challenge Ashgate chapter, 2000;15:269-286.
123. Whiffin, V: The comparisons of Postpartum with Non-postpartum Depression; A Rose by Any Other Name, Journal of Psychiatric Neuroscience, 1991; 16(3).
124. WHO Mental Health Declaration and action plan for Europe, 2004.